Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Soma Soltani"'
Autor:
Soma Soltani, Ella Grezchnik, Leanne Easton, Jane McDonald, James W.C. Favaloro, Emmanuel J. Favaloro
Publikováno v:
American Journal of Clinical Pathology. 124:910-917
We reassessed the influence of ABO blood group, sex, and age on plasma levels of von Willebrand factor (vWF) antigen, vWF:ristocetin cofactor, vWF:collagen binding assay, and factor VIII coagulant (FVIII:C). Data show that levels of vWF and FVIII:C i
Publikováno v:
Laboratory Hematology. 11:174-184
Laboratory testing for familial thrombophilia defines a large proportion of the modern hemostasis laboratory workload. As part of an ongoing assessment of our activities, we have re-evaluated our laboratory procedures for antithrombin (AT), Protein C
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 4(9)
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 16(8)
We have assessed the influence of the ABO blood group, gender and age on plasma levels of the coagulation factors II, V, VII, VIII, IX, X, XI and XII as part of a quality audit of laboratory activities. There was no statistically significant differen
Publikováno v:
Thrombosis research. 117(6)
We have evaluated the potential influence of ABO-blood group, gender and age, on laboratory procedures used for detection of Activated Protein C Resistance (APCR), using over 300 normal donor samples and two distinct laboratory test procedures, one b
Autor:
Sarah Just, Geoff Kershaw, Joyce Low, Margaret Aboud, Simon McRae, Emmanuel J. Favaloro, Robyn Coleman, Soma Soltani, Mark Dean, Rosalie Gemmell, Jennifer Posen, Raj Ramakrishna
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 15(8)
Acquired deficiencies of, or inhibitors to, factor V are considered rare events. We report a series of 14 acquired factor V deficiencies, 10 of which were confirmed to have inhibitors to factor V, as identified within Australia in the past 5 years fo
Publikováno v:
American journal of clinical pathology. 122(5)
To assess the potential for misdiagnosis of von Willebrand disorder (vWD) and hemophilia A while following current National Committee for Clinical Laboratory Standards (NCCLS) guidelines and consequent to a poorly recognized cold-activation phenomeno